Gerwald A. Koehler

Dr. Gerwald A. Koehler


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2005 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
BBBurkhard R Braun
Burkhard R Braun
MHMarco van Het Hoog
Marco van Het Hoog
CDChristophe D'ENfert
Christophe D'ENfert
MMMikhail Martchenko
Mikhail Martchenko
JDJan Dungan
Jan Dungan
ANAndré Nantel
André Nantel
Recent sequencing and assembly of the genome for the fungal pathogen Candida albicans used simple automated procedures for the identification of putative genes. We have reviewed the entire assembly, both by hand and with additional bioinformatic resources, to accurately map and describe 6,354 genes and to identify 246 genes whose original database entries contained sequencing errors (or possibly mutations) that affect their reading frame. Comparison with other fungal genomes permitted the identification of numerous fungus-specific genes that might be targeted for antifungal therapy. We also observed that, compared to other fungi, the protein-coding sequences in the C. albicans genome are especially rich in short sequence repeats. Finally, our improved annotation permitted a detailed analysis of several multigene families, and comparative genomic studies showed that C. albicans has a far greater catabolic range, encoding respiratory Complex 1, several novel oxidoreductases and ketone body degrading enzymes, malonyl-CoA and enoyl-CoA carriers, several novel amino acid degrading enzymes, a variety of secreted catabolic lipases and proteases, and numerous transporters to assimilate the resulting nutrients. The results of these efforts will ensure that the Candida research community has uniform and comprehensive genomic information for medical research as well as for future diagnostic and therapeutic applications. Candida albicans is a commonly encountered fungal pathogen usually responsible for superficial infections (thrush and vaginitis). However, an estimated 30% of severe fungal infections, most due to Candida, result in death. Those who are most at risk include individuals taking immune-suppressive drugs following organ transplantation, people with HIV infection, premature infants, and cancer patients undergoing chemotherapy. Current therapies for this pathogen are made more difficult by the significant secondary effects of anti-fungal drugs that target proteins that are also found in the human host. Recent sequencing and assembly of the genome for the fungal pathogen C. albicans used simple automated procedures for the identification of putative genes. Here, we report a detailed annotation of the 6,354 genes that are present in the genome sequence of this organism, essentially writing the dictionary of the C. albicans genome. Comparison with other fungal genomes permitted the identification of numerous fungus-specific genes that are absent from the human genome and whose products might be targeted for antifungal therapy. The results of these efforts will thus ensure that the Candida research community has uniform and comprehensive genomic information for medical research, for the development of functional genomic tools as well as for future diagnostic and therapeutic applications.

1 January 2012 in Infectious Diseases in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
GKGerwald A. Koehler
Gerwald A. Koehler
SASenait Assefa
Senait Assefa
GRGregor Reid
Gregor Reid
Candida albicansis the most importantCandidaspecies causing vulvovaginal candidiasis (VVC). VVC has significant medical and economical impact on women’s health and wellbeing. While current antifungal treatment is reasonably effective, supportive and preventive measures such as application of probiotics are required to reduce the incidence of VVC. We investigated the potential of the probioticsLactobacillus rhamnosusGR-1 andLactobacillus reuteriRC-14 towards control ofC. albicans.In vitroexperiments demonstrated that lactic acid at low pH plays a major role in suppressing fungal growth. Viability staining following cocultures with lactobacilli revealed thatC. albicanscells lost metabolic activity and eventually were killed. Transcriptome analyses showed increased expression of stress-related genes and lower expression of genes involved in fluconazole resistance, which might explain the increased eradication ofCandidain a previous clinical study on conjoint probiotic therapy. Our results provide insights on the impact of probiotics onC. albicanssurvival.

1 October 2006 in International Journal of Medical Microbiology
Verified
Journal Article
Open access
STStephanie Theiss
Stephanie Theiss
GIGanchimeg Ishdorj
Ganchimeg Ishdorj
ABAudrey Brenot
Audrey Brenot
MKMarianne Kretschmar
Marianne Kretschmar
CLChung-Yu Lan
Chung-Yu Lan
GKGerwald A. Koehler
Gerwald A. Koehler
Phospholipases are critical for modification and redistribution of lipid substrates, membrane remodeling and microbial virulence. Among the many different classes of phospholipases, fungal phospholipase B (Plb) proteins show the broadest range of substrate specificity and hydrolytic activity, hydrolyzing acyl ester bonds in phospholipids and lysophospholipids and further catalyzing lysophospholipase-transacylase reactions. The genome of the opportunistic fungal pathogen Candida albicans encodes a PLB multigene family with five putative members; we present the first characterization of this group of potential virulence determinants. CaPLB5, the third member of this multigene family characterized herein is a putative secretory protein with a predicted GPI-anchor attachment site. Real-time RT-PCR gene expression analysis of CaPLB5 and the additional CaPLB gene family members revealed that filamentous growth and physiologically relevant environmental conditions are associated with increased PLB gene activity. The phenotypes expressed by null mutant and revertant strains of CaPLB5 indicate that this lipid hydrolase plays an important role for cell-associated phospholipase A(2) activity and in vivo organ colonization.

1 May 1999 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
PSPeter Staib
Peter Staib
MKMarianne Kretschmar
Marianne Kretschmar
TNThomas Nichterlein
Thomas Nichterlein
GKGerwald A. Koehler
Gerwald A. Koehler
SMSonja Michel
Sonja Michel
JMJoachim Morschhäuser
Joachim Morschhäuser
An understanding of the complex interactions between pathogenic microbes and their host must include the identification of gene expression patterns during infection. To detect the activation of virulence genes in the opportunistic fungal pathogen Candida albicans in vivo by host signals, we devised a reporter system that is based on FLP‐mediated genetic recombination. The FLP gene, encoding the site‐specific recombinase FLP, was genetically modified for expression in C. albicans and fused to the promoter of the SAP2 gene that codes for one of the secreted aspartic proteinases, which are putative virulence factors of C. albicans. The SAP2P–FLP fusion was integrated into one of the SAP2 alleles in a strain that contained a deletable marker that conferred resistance to mycophenolic acid and was flanked by direct repeats of the FLP recognition target (FRT). Using this reporter system, a transient gene induction could be monitored at the level of single cells by the mycophenolic acid‐sensitive phenotype of the colonies generated from such cells after FLP‐mediated marker excision. In two mouse models of disseminated candidiasis, SAP2 expression was not observed in the initial phase of infection, but the SAP2 gene was strongly induced after dissemination into deep organs. In contrast, in a mouse model of oesophageal candidiasis in which dissemination into internal organs did not occur, no SAP2 expression was detected at any time. Our results support a role of the SAP2 gene in the late stages of an infection, after fungal spread into deep tissue. This new in vivo expression technology (IVET) for a human fungal pathogen allows the detection of virulence gene induction at different stages of an infection, and therefore provides clues about the role of these genes in the disease process.

1 November 2006 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
GKGerwald A. Koehler
Gerwald A. Koehler
ABAudrey Brenot
Audrey Brenot
EHEric Haas-Stapleton
Eric Haas-Stapleton
NANina Agabian
Nina Agabian
RDRupal Deva
Rupal Deva
SNSantosh Nigam
Santosh Nigam

1 July 2006 in Infection and Immunity
Verified
Journal Article
Closed access
TBTeresa Bader
Teresa Bader
KSKlaus Schröppel
Klaus Schröppel
SBStefan Bentink
Stefan Bentink
NANina Agabian
Nina Agabian
GKGerwald A. Koehler
Gerwald A. Koehler
2M27.05.2021 Fungal infections Joachim Morschhäuser
27.05.2021 Fungal infections Joachim Morschhäuser
By generating a calcineurin mutant of the Candida albicans wild-type strain SC5314 with the help of a new recyclable dominant selection marker, we confirmed that calcineurin mediates tolerance to a variety of stress conditions but is not required for the ability of C. albicans to switch to filamentous growth in response to hypha-inducing environmental signals. While calcineurin was essential for virulence of C. albicans in a mouse model of disseminated candidiasis, deletion of CMP1 did not significantly affect virulence during vaginal or pulmonary infection, demonstrating that the requirement for calcineurin for a successful infection depends on the host niche.